Archive for Tuesday, February 2, 2010

Experiment takes aim at learning disorder

February 2, 2010


— A pill to ease a type of mental retardation? An experiment is under way to develop one, aimed at a genetic disorder that might unravel some of the mysteries of autism along the way.

Chances are you’ve never heard of the target — Fragile X syndrome — even though it’s the most common inherited form of intellectual impairment, estimated to affect almost 100,000 Americans. It’s also the most common cause of autism yet identified, as about a third of Fragile X-affected boys have autism.

Now a handful of drug makers are working to develop the first treatment for Fragile X, spurred by brain research that is making specialists rethink how they approach developmental disorders.


Amy Heeter 8 years, 3 months ago

Even if they stopped using thimerosal there would still be as many cases of autisim and other LD's. People seem to forget that years ago there was a blanket diagnosis of "retardation". Now we know that all LD's are not in fact as simple as that. Before immunizations children died because they were not protected. Through ignorance we knew no better, It would be insane to stop giving children immunizations and risk death rather than seek other alternatives to the content of medications.

Commenting has been disabled for this item.